TargetMol

AZD-6280

Product Code:
 
TAR-T7136
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7136-1mg1mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7136-5mg5mg£550.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7136-1mL1 mL * 10 mM (in DMSO)£598.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7136-10mg10mg£755.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7136-25mg25mg£1,107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7136-50mg50mg£1,460.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7136-100mg100mg£1,958.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AZD6280 is a novel, subtype-selective GABAAα2/3 receptor positive modulators, used for treatment of generalized anxiety disorder.
CAS:
942436-93-3
Formula:
C20H22N4O3
Molecular Weight:
366.421
Pathway:
Neuroscience; Membrane transporter/Ion channel
Purity:
0.98
SMILES:
CCCNC(=O)c1nnc2c(cccc2c1N)-c1cc(OC)ccc1OC
Target:
GABA Receptor

References

Te Beek E T , Chen X , Jacobs G E , et al. The effects of the nonselective benzodiazepine lorazepam and the ?2 /?3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.[J]. Clin Pharmacol Drug Dev, 2015, 4(2):149-154. Jucaite A , Csel?nyi, Zsolt, Lappalainen J , et al. GABAAreceptor occupancy by subtype selective GABAA?2,3modulators: PET studies in humans[J]. Psychopharmacology, 2017, 234(4):707-716.